Skip to content

Ovarian Cancer Video

View learning videos on topics related to evaluation, management and treatment decisions within the Ovarian cancer space.

MDS/AML Considerations with Maintenance PARP Inhibitor Therapy

Speaker: Dr. Aalok Kumar

Learn about MDS/AML consideration when using PARPi therapy.

To provide program feedback take this survey. Questions?
Email: CAN.HCPE-ONCOLOGY@gsk.com.

NP-CA-AOU-WCNT-220001 | August 2022